More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...

We recently compiled a list of the 12 Stocks That Will Double in 2025. In this article, we are going to take a look at where ...

The Warren-headquartered clinical-stage specialty immunotherapy biotechnology company focuses on the development of T-cell ...

India needs to grow at 8 percent for up to two decades to become a developed nation by 2047, the Economic Survey said on ...

President Trump has inherited an evolving chemical and biological threat landscape, but not one he hasn’t encountered before.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, today we look at ...

In this article, we will take a look at the 12 stocks that will double in 2025.

India needs to grow at 8 per cent for up to two decades to become a developed nation by 2047, the Economic Survey said on Friday, pitching for a slew of reforms, including land and labour, to achieve ...

We recently compiled a list of the 12 Stocks That Will Double in 2025. In this article, we are going to take a look at where ...

A graduate of Stanford University's prestigious EENT Innovation Biodesign program in 2019, Diag-Nose.io is redefining ...

In a turbulent period for biotech firms, Evaxion Biotech AS (EVAX) has seen its stock price plummet to $2.38, though InvestingPro analysis suggests the stock may be undervalued. According to ...

Businesses in the East of England received more than £480m in venture capital investment during the final quarter of last year – a 61pc ...